ClinicalTrials.Veeva

Menu

Patient Satisfaction in Stroke Patients (PatZuFrie)

Charité University Medicine Berlin logo

Charité University Medicine Berlin

Status

Completed

Conditions

Stroke

Study type

Observational

Funder types

Other

Identifiers

NCT00994409
CSB-PatZuFrie
EA4/019/08

Details and patient eligibility

About

The objective of this trial is to guarantee a follow-up of all stroke and transient ischemic attack (TIA) patients. With this follow-up assessment long term effects of therapy and prevention measures can be detected and monitored. It is part of quality assurance.

Full description

Primary efficacy endpoint: Number of patients who state that they received all the information they want about the causes and nature of their illness Key secondary endpoint(s): Compliance/adherence with discharge medication. Re-events. Degree of Disability. Activities of daily living. Mortality.

Enrollment

1,200 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • all patients eligible

Exclusion criteria

  • none

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems